Skip to main content
Bayer to pay $240M to get 100% of biotech startup BlueRock
8/9/2019

Bayer, which currently owns a 40.8% stake in the biotech startup BlueRock Therapeutics, said it has agreed to pay $240 million for all of the company's remaining shares. Bayer could pay as much as an additional $360 million based upon progress made on several of the company's projects.

Full Story: